SunTrust Banks Research Analysts Reduce Earnings Estimates for LifePoint Health, Inc. (LPNT)
LifePoint Health, Inc. (NASDAQ:LPNT) – Stock analysts at SunTrust Banks lowered their FY2019 earnings estimates for LifePoint Health in a report issued on Tuesday. SunTrust Banks analyst D. Macdonald now anticipates that the company will post earnings per share of $4.70 for the year, down from their prior forecast of $5.12.
LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.06. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. The business had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the previous year, the company earned $0.69 EPS. The business’s quarterly revenue was up .2% compared to the same quarter last year.
ILLEGAL ACTIVITY WARNING: “SunTrust Banks Research Analysts Reduce Earnings Estimates for LifePoint Health, Inc. (LPNT)” was originally reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece on another site, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.dailypolitical.com/2017/08/06/suntrust-banks-research-analysts-reduce-earnings-estimates-for-lifepoint-health-inc-lpnt.html.
Other research analysts have also issued reports about the stock. BidaskClub lowered shares of LifePoint Health from a “buy” rating to a “hold” rating in a report on Saturday, July 8th. Zacks Investment Research downgraded LifePoint Health from a “buy” rating to a “hold” rating in a research report on Tuesday, July 11th. Royal Bank Of Canada reiterated a “buy” rating and set a $77.00 target price on shares of LifePoint Health in a research report on Wednesday, July 5th. Leerink Swann upgraded LifePoint Health from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $73.00 to $74.00 in a research report on Tuesday, June 6th. Finally, Morgan Stanley started coverage on LifePoint Health in a research report on Tuesday, June 6th. They set an “equal weight” rating and a $65.00 target price for the company. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $66.18.
Shares of LifePoint Health (NASDAQ LPNT) opened at 58.45 on Friday. The company has a market capitalization of $2.34 billion, a price-to-earnings ratio of 13.09 and a beta of 0.86. The stock has a 50 day moving average of $64.73 and a 200-day moving average of $62.97. LifePoint Health has a one year low of $50.60 and a one year high of $70.95.
In other LifePoint Health news, Chairman William F. Carpenter III sold 17,653 shares of the stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $65.06, for a total value of $1,148,504.18. Following the sale, the chairman now owns 439,841 shares of the company’s stock, valued at approximately $28,616,055.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard H. Evans sold 2,000 shares of the stock in a transaction dated Thursday, May 11th. The shares were sold at an average price of $62.88, for a total value of $125,760.00. Following the completion of the sale, the director now directly owns 17,718 shares in the company, valued at approximately $1,114,107.84. The disclosure for this sale can be found here. Insiders have sold a total of 102,000 shares of company stock valued at $6,556,824 over the last 90 days. 7.28% of the stock is currently owned by company insiders.
A number of large investors have recently bought and sold shares of LPNT. LS Investment Advisors LLC boosted its stake in shares of LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock worth $120,000 after buying an additional 543 shares during the period. US Bancorp DE boosted its stake in shares of LifePoint Health by 1.6% in the first quarter. US Bancorp DE now owns 1,931 shares of the company’s stock worth $127,000 after buying an additional 30 shares during the period. Bank of Montreal Can boosted its stake in shares of LifePoint Health by 18.7% in the first quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock worth $128,000 after buying an additional 306 shares during the period. Teacher Retirement System of Texas acquired a new stake in shares of LifePoint Health during the first quarter worth about $210,000. Finally, Regent Investment Management LLC acquired a new stake in shares of LifePoint Health during the first quarter worth about $230,000. 98.75% of the stock is currently owned by institutional investors.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.